Isabel Barao-Silvestre
Isabel Barao-Silvestre, aka Isabel Barao, Ph.D., is a cancer immunologist[1] and a Research Assistant Professor of Microbiology and Immunology at University of Nevada Reno, Nevada, US.[2] She is researching the causes of abnormal NK cell functioning in ME/CFS patients and its use as a potential biomarker for ME/CFS.[1]
From 2013 to 2015, Barao-Silvestre worked as the Scientific Director of Simmaron Research, Incline Village, Nevada.[3]
In 2016, Barao-Silvestre was awarded a grant from Solve ME/CFS Initiative Ramsay Award Program for the project, “The Bioenergetic Health Index of NK Cells as a Diagnostic Tool for Chronic Fatigue Syndrome.”[4][5] in 2017, she was awarded a grant from the National Institute Of Allergy And Infectious Diseases for "Risk of CFS Due to IgG Receptor Genes that Impair ADCC."[6]
Notable studies[edit | edit source]
- 2019, Mitochondrial alterations in NK lymphocytes from ME/CFS patients[7] - (Abstract)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
- Uncovering Biomarkers – Fcg receptors in ME/CFS, by Suzanne D Vernon, PhD for Bateman Horne Center newsletter
References[edit | edit source]
- ↑ 1.0 1.1 "Uncovering Biomarkers - Fcg Receptors in ME/CFS". Bateman Horne Center. April 15, 2016. Retrieved August 9, 2019.
- ↑ "Noteworthy News for December 2016". Health Sciences. Retrieved August 9, 2019.
- ↑ "Isabel Barao". LinkedIn. Retrieved August 9, 2019.
- ↑ "2016 Ramsay Award Program Results". Solve ME/CFS Initiative. Retrieved August 9, 2019.
- ↑ "The Bioenergetic Health Index of NK Cells as a Diagnostic Tool for Chronic Fatigue Syndrome". Solve ME/CFS Initiative. December 7, 2016. Retrieved August 9, 2019.
- ↑ "Risk of CFS Due to IgG Receptor Genes that Impair ADCC | National Institute Of Allergy And Infectious Diseases". ResearchGate. Retrieved August 9, 2019.
- ↑ Darley-Usmar, Victor; Dagda, Ruben K.; Dagda, Raul Y. Dagda; Silvestre, Isabel Barao (May 1, 2019). "Mitochondrial alterations in NK lymphocytes from ME/CFS patients". The Journal of Immunology. 202 (1 Supplement): 126.39–126.39. ISSN 0022-1767.
